ExitValue.ai

BUYER POOL ANALYSIS

Selling a Home Health to Private Equity / PE-Backed Roll-Up buyers

Private equity firms and PE-backed platform consolidators acquiring for roll-up, add-on, or platform plays. Pricing tends to lead the market for fee-viable scale, with multi-bidder competitive processes above the EBITDA floor.

Quick answers

What multiple does this buyer pool pay?
Median EV/EBITDA 10.45x across 19 disclosed deals (P25: 8.09x, P75: 12.98x). Median EV/Revenue 0.86x across 29 deals. Median deal value: $451.11M.
How many disclosed transactions?
30 deals total (6 from 2018+), filtered to Private Equity / PE-Backed Roll-Up acquirers of home health businesses.
Most active buyers
Onex Corporation (3) · Encompass Health Corporation (2) · National Health Industries Inc. (2) · Kinderhook Industries (1) · Aveanna Healthcare Senior Services LLC (1) · Socrates LLC (1)

Recent disclosed deals

Private Equity / PE-Backed Roll-Up acquisitions of home health businesses with named target, named acquirer, and disclosed financials.

YearTargetAcquirerEVEV/EBITDAEV/Rev
2026Enhabit Home Health & HospiceKinderhook Industries$1100.0M11.0x1.05x
2021Comfort Care Home Health Services, LLCAveanna Healthcare Senior Services LLC$338.9M21.2x3.64x
2020Simplura Health GroupSocrates LLC$575.0M11.6x1.24x
2018Camellia HealthcareEncompass Health Corporation$135.0M1.73x
2018Jordan Health ServicesBlue Wolf Capital Partners/Kelso & Co$700.0M10.4x
2018Kindred Healthcare (Home Health Division)Humana / TPG Capital / Welsh Carson$4100.0M10.3x1.28x

What this buyer pool prices for

Private equity acquirers price for scale and roll-up arbitrage. They pay up for businesses that fit a platform thesis — recurring revenue mix above 30%, technician/professional depth, clean financials, and a management layer that survives integration. The same home health can command 1.5x to 2x the multiple of an individual-buyer transaction simply because the PE buyer is acquiring a platform piece, not an owner-operated shop.

Methodology note

Multiples shown are computed from disclosed M&A transactions in the ExitValue.ai database, filtered to home health businesses acquired by private equity / pe-backed roll-up buyers. EV/EBITDA outliers outside the [0.5x, 60x] band and EV/Revenue outliers outside [0.05x, 25x] are excluded from medians. Where available, post-2018 transactions are weighted; otherwise the all-time sample is used. Deal counts shown reflect deals with disclosed financials only — total transaction count for this buyer pool is typically 2-3x larger. Full methodology

What's your home health worth to private equity / pe-backed roll-up?

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Engine-grounded estimate. Comparable private equity / pe-backed roll-up deals on the full results page.

Last verified against 30 disclosed M&A transactions on 2026-05-05 · methodology